1. Home
  2. AEHR vs OBIO Comparison

AEHR vs OBIO Comparison

Compare AEHR & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aehr Test Systems

AEHR

Aehr Test Systems

HOLD

Current Price

$20.40

Market Cap

716.3M

Sector

Industrials

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$4.19

Market Cap

237.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEHR
OBIO
Founded
1977
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
716.3M
237.2M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
AEHR
OBIO
Price
$20.40
$4.19
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$14.00
AVG Volume (30 Days)
516.4K
202.4K
Earning Date
01-09-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$56,818,000.00
$2,818,000.00
Revenue This Year
$2.55
$35.75
Revenue Next Year
$34.99
$3.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.46
52 Week Low
$6.27
$2.20
52 Week High
$34.35
$6.30

Technical Indicators

Market Signals
Indicator
AEHR
OBIO
Relative Strength Index (RSI) 38.55 44.27
Support Level $21.34 $4.07
Resistance Level $23.20 $4.37
Average True Range (ATR) 1.45 0.25
MACD -0.25 -0.06
Stochastic Oscillator 2.19 16.80

Price Performance

Historical Comparison
AEHR
OBIO

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Share on Social Networks: